Ph+/Bcr-Abl+ ALL Imatinib and Nilotinib Rotational Study

Clinical trial NCT01025505 · COMPLETED

Trial details

NCT number: NCT01025505
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Treatment Stem Cell Transplantation

Start date: 2012-06-01
Primary completion: 2015-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.